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Graphical abstract 
Heading Highlights 
● High prevalence of sub-microscopic infection at delivery.
● High genetic diversity of Plasmodium falciparum strains in Congo that varies according to
peripheral, placental and umbilical cord blood.
● Reduction of multiplicity of infections.
Abstract 
In malaria-endemic areas, most pregnant women are susceptible to asymptomatic 
Plasmodium falciparum infections. We present here the results of a cross-sectional study 
conducted in Madibou, a southern district of Brazzaville in the Republic of Congo, between 
March 2014 and April 2015. The main aim was to characterize P. falciparum infections. 
Blood samples corresponding to peripheral, placental and cord from 370 asymptomatic 
malaria women at delivery were diagnosed for plasmodium infection by thick blood smears 
(microscopic infection). Sub-microscopic infection was detected by PCR, using the MSP-2 
gene as marker. Microscopic infections were detected in peripheral, placental and cord 
blood samples with a prevalence of respectively 7.3% (27/370), 2.7% (10/370) and 0%. 
The negative samples were submitted to sub-microscopic detection, with respective 
prevalence of 25.4% (87/343), 16.7% (60/360) and 9.4% (35/370) (P < 0.001). We further 
investigated the genetic diversity of the parasite by characterizing MSP2 allelic families 
3D7 (24 distinct alleles) and FC27 (20 distinct alleles). The total number of alleles for these 
two families were 31, 25 and 19 in peripheral, placental and cord samples respectively. 
The 3D7 MSP-2 was the predominant allelic family. The multiplicity of infections (MOI) in 
peripheral (mean 1.4±0.01; range 1-4), placental (mean 1.2±0.01; range 1-3) and cord 
samples (1.4±0.01; range 1-3) were similar (P = 0.9) and are unaffected by age, gravidity 
or sulfadoxine-pyrimethamine. These results shown a high prevalence of sub-microscopic 
infection and a high genetic diversity of Plasmodium falciparum strains in Congo. Age, 
gravidity and doses of preventive treatment based on sulfadoxine-pyrimethamine do not 
interfere with the multiplicity of infections. 
Keywords: asymptomatic pregnant women, Plasmodium falciparum, genetic diversity, 
multiplicity of infections, Congo. 
1. Introduction
Malaria infection during pregnancy is a serious public health issue in sub-Saharan Africa 
with approximately 30 million pregnant women being at risk of pregnancy-associated-
malaria (Dellicour et al., 2010). The symptoms and complications of malaria infection 
during pregnancy may vary according to the level of malaria transmission in different 
geographical areas and the level of acquired immunity (Okell et al., 2009). In high-
transmission areas, most infections during pregnancy are asymptomatic but still result in 
poor pregnancy outcome (Steketee et al., 1996; Mockenhaupt et al., 2000; Nosten et al., 
2004). A high proportion of individuals living in malaria-endemic areas harbour P. 
falciparum parasites undetectable by microscopy — therefore called sub-microscopic 
infection — which can nevertheless be identified using molecular tools like PCR (Snounou 
et al., 1993). Sub-microscopic infection is common during pregnancy and at delivery 
(Cottrell et al., 2015). To reduce the burden of malaria infections in pregnant women, the 
World Health Organization (WHO) has recommended a package of interventions, including 
the use of long-lasting insecticidal nets (LLINs) and administration of sulfadoxine- 
pyrimethamine (SP) as intermittent preventive treatment of malaria during pregnancy 
(IPTp) (WHO, 2005). In the Republic of Congo, a malaria-endemic country in Central 
Africa with perennial transmission (Trape and Zoulani, 1987), the administration of IPTp-
SP (2 or 3 doses) during pregnancy has been in place since 2006. The study conducted in 
asymptomatic pregnant women in Brazzaville revealed a reduction of the prevalence of P. 
falciparum infection (Ntoumi et al., 2016). However, high resistance to SP has been found 
in parasites collected from Congolese pregnant women (Koukouikila-Koussounda et al., 
2015). The development of an effective vaccine is the one of the major challenges of the 
fight against malaria. However, this approach is limited by the polymorphic nature of 
Plasmodium (Mayengue et al., 2004; Francine et al., 2016; Guitard et al., 2010; Cohee et 
al., 2016). The susceptibility of pregnant women to malaria is explained by the presence of 
parasite strains that specifically bind to the chondroitin sulphate A (CSA) present in the 
placental tissue (Fried and Duffy, 1996; Duffy and Fried, 1999). Investigating of genotype 
and the circulating parasites in pregnant women is interesting for the malaria vaccine 
(Genton et al., 2002; Takala et al., 2007; Takala and Plowe, 2009). Several previous 
studies on the antigenic diversity of P. falciparum matched in peripheral, placental and 
umbilical cord blood have shown varied results in different country. Some studies have 
shown a parasitic overlap found for each of these compartments while others have 
revealed a subpopulation of peripheral parasites sequestered in the placenta (Kassberger 
et al., 2002; Mayengue et al., 2004; Fadlelseed et al., 2017; Guitard et al., 2010; Cohee et 
al., 2016). Recent published work conducted in the same area reported 29 MSP-2 alleles 
in isolates from peripheral blood of pregnant women with asymptomatic P. falciparum 
infection at antenatal visits, suggesting a wide diversity of the P. falciparum population 
(Francine et al., 2016). Therefore, the present cross-sectional study was conducted to 
characterize P. falciparum infections matched in peripheral, placental and cord blood 
among Congolese women at delivery receiving 1, 2 or more doses of sulfadoxine-
pyrimethamine. 
2. Materials and methods
2.1. Study site 
The study was carried out at Madibou Integrated Health Center, located in the semi-urban 
area of Makélékélé district, Southern part of Brazzaville, the capital of the Republic of 
Congo. This area with about 6.000 inhabitants is situated along the Congo River, where 
malaria transmission is intense and continuous throughout the year. The entomological 
inoculation rate is approximately 23 infective bites/person/year (Trape and Zoulani, 1987). 
P. falciparum is the predominant malaria species and Anopheles gambiae s.s the main 
mosquito vector. 
2.2. Study population 
Between March 2014 and April 2015, a total of 370 pregnant women were recruited at the 
maternity ward. The inclusion criteria were as follows: signed informed consent obtained 
from the participant at admission before delivery, no episodes of clinical malaria during the 
last two weeks, no notion of fever at least 48 hours before enrolment and an axillary 
temperature ≤ 37.5 ° C during the examination. Socio-demographic data were recorded 
using a structural questionnaire and from medical records. 
2.3. Ethics 
The study was approved by the Institutional Ethics Committee of the Fondation Congolaise 
pour la Recherche Médicale (ethical clearance No 001/CEI/FCRM/2012). Written informed 
consent was obtained from all pregnant women before enrolment. 
2.4. Blood collection and treatment of samples 
A total volume of 5 ml of peripheral blood was collected before delivery, 5 ml placental 
intervillous and umbilical cord blood were collected within 30 min after delivery into EDTA 
tubes for the detection of and quantification of malaria parasites. Thick blood smears were 
 
prepared for each blood compartment, stained with 10% Giemsa solution for 15 min, and 
examined by an experienced microscopist. Trophozoites were counted concomitantly with 
200 leukocytes, and expressed in number of asexual parasites per μL of blood, assuming 
the leukocyte count of 8.000/μL of blood. The rest of the blood was spun to separate cells 
from plasma and stored separately at -20°C for future use. 
2.5. DNA extraction and characterization of P. falciparum isolates 
Genomic DNA was extracted separately from peripheral, placental and cord blood using 
the QIAmp DNA Blood Mini kit (QIAGEN GmbH, Hilden, Germany) according to 
manufacturer instructions. Parasite isolates were genotyped for P. falciparum using the 
nested PCR technique, targeting the highly polymorphic locus MSP-2 central region as 
previously described (Francine et al., 2016). The initial amplifications were followed by 
individual nested PCR reactions, using specific primers for FC27 and 3D7 allelic families of 
the MSP-2 gene. Allele-specific positive controls (3D7 and Dd2) and DNA-free water as a 
negative control were included in each set of reactions. Each PCR product was stained 
with Sybr Green, loaded on a 2% agarose gel, and visualized under ultraviolet trans-
illumination. Various alleles were determined by their amplicon sizes and the 
corresponding allele-specific primers used. The sizes of PCR product were estimated 
using a 100 bp DNA ladder marker (Invitrogen, Karlsruhe, Germany). It was assumed that 
one band represented one amplified PCR fragment derived from a single copy of P. 
falciparum MSP-2 gene. Alleles in each family were considered as one if fragment sizes 
were within a 20 bp interval. The number of different MSP-2 fragments identified per 
isolate was considered as the minimum number of parasite genotypes present in this 
isolate. The amplified PCR products from the different blood compartments for the one 
woman were run in the same gel to ensure a better comparison. 
2.6. Case definitions 
Asymptomatic P. falciparum infection was defined as the presence of malaria parasites in 
blood in the absence of any clinical symptom. Peripheral, placental and cord blood isolates 
were grouped into a) P. falciparum microscopy positive infection; b) P. falciparum infection 
 
that were negative by microscopy but detected by PCR (sub-microscopic infection); c) 
negative individuals who were negative by both microscopy and PCR. The genetic 
diversity of MSP-2 alleles was determined as the total number of different MSP-2 
fragments amplified. The multiplicity of infection (MOI) was defined as the mean number of 
P. falciparum genotypes per infected woman. Gravidity was grouped as paucigravidae 
(First and second full-term pregnancies), and multigravidae (3rd full term pregnancies). 
2.7. Statistical analysis 
All statistical analyses were performed using R (version 3.5.1) under the RStudio 
environment (1.1.456). To evaluate the impact of different factors (age, gravidity, SP), we 
applied non-parametric tests, since the multiplicity of infections takes discrete values, and 
does thus not comply with the normality assumption required for parametric tests. For two-
group comparisons (age, gravidity) we applied Wilcoxon test. For multi-group comparisons 
(number of SP doses) we ran a Kruskal-Wallis test. For multi-group comparisons between 
compartments (prevalence of infection; allelic diversity), we applied the Kruskal-Wallis test. 
The statistical significance threshold was set to P < 0.05. 
3. Results
3.1. Characteristics of the study population 
From March 2014 to April 2015, a total of 370 women were enrolled in the study. The 
characteristics of the women are shown in Table 1. 
Table 1. Characteristics of the Congolese women at delivery. The age and gestational age are given as 
mean plus or minus standard deviation. N = number of women in each group. 
Parameters Values (N = 370) 
Mean age ± SD (years) 25.9±6.45. 
Mean gestational age ± SD (weeks) 38.1±1.9 
Gravidity, n (%) 
    Paucigravidae 152 (41%) 
    Multigravidae 218 (59%) 
Number of IPTp-SP doses 
    No 60 (16.2%) 
    1 dose 106 (28.6) 
    2 doses 95 (25.7%) 
    3 doses 112 (30.3%) 
3.2. Prevalence of P. falciparum asymptomatic infection 
Overall, matched peripheral, placental and cord blood samples from all study participants 
were analysed. The prevalence of P. falciparum microscopic infection in peripheral blood 
was 7.3% and that of placental blood was 2.7% (Table 2). Not a single sample was found 
microscopic positive in cord blood (Table 2). The prevalence of P. falciparum sub-
microscopic infections was 25.4% in peripheral blood, 16.7% in placental blood and 9.4% 
in cord blood (Table 2). All the microscopy-positive peripheral and placental blood samples 
were positive by PCR. The overall (microscopy-positive and sub-microscopic infections put 
together) prevalence of P. falciparum sub-microscopic infection was 30.8% in peripheral 
blood and 19.4% in placental blood (Table 2).  
Table 2. Prevalence of MSP-2 P. falciparum infections in Congolese women at delivery. 
N: number of women recruited in this study. For each woman, we collected three blood samples 
corresponding for peripheral, placenta and cord. 
 
9 
N = 370 Peripheral, n (%) Placenta, n (%) Cord, n (%) P 
Infections 
Microscopy 27/370 (7.9) 10/370 (2.7) 0/370 (0.0) 0.005 
Sub-microscopy 87/343 (25.4) 60/360 (16.7) 35/370 (9.5) < 0.001 
Total PCR 114/370 (30.8) 70/370 (19.4) 35/370 (9.5) < 0.001 
Out of 87 (25.4%) of women with peripheral sub-microscopic infections, 9 (4.6%) had 
placental infections and 11 (12.6%) had infections in cord. Out of 60 (16.7%) of women 
with placental sub-microscopic infections, 4 (6.7%) samples were matched in cord. 
Furthermore, 62 (71.3%), 42 (70%) and 15 (42.8%) positive samples were detected 
exclusively in peripheral, placental and cord respectively. Overall, 5 cases of P. falciparum 
sub-microscopic infections matched in peripheral, placental and cord samples (Fig. 1).  
Fig. 1: Sub-microscopic P. falciparum infections in Congolese women at delivery matched in peripheral, 
placental and cord blood. 
3.3. Distribution of P. falciparum MSP-2 alleles 
With regard to the genetic diversity, the distribution of different MSP-2 alleles is shown in 
Table 3. A total, 30, 25 and 19 (P = 0.29) alleles were detected respectively in the 
peripheral, placental and cord samples. The 3D7 family was predominant whatever sample 
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types. The mixed 3D7 and FC27 alleles were more prevalent in peripheral samples 
(26.3%) (Table 3). 
Table 3. Genetic diversity of P. Falciparum MSP-2 gene. Total Nb. of alleles: total number of 3D7 and 
FC27 alleles of each compartment.  
Nb. of samples (%) Fragment size range (bp) Total Nb. of alleles (%) 
Alleles Periphery Placenta Cord P Peripher
y 
Placenta Cord Periphery Placenta Cord 
3D7 62 (54.4) 42 (60) 16 (45.7) <0.001 180-680 140-600 120-480 16 (51.6) 14 (56) 12 (63.2) 
FC27 22 (19.3) 20 (28.6) 11 (31.4) 0.14 260-620 260-540 240-520 14 (48.4) 11 (44) 7 (36.8) 
3D7 + FC27 30 (26.3) 8 (11.4) 8 (22.9) <0.001 
Total 114 (100) 70 (100) 35 (100) <0.001 30 (100) 25 (100) 19 (100) 
The 3D7 and FC27 alleles identified in the paired peripheral / placental, peripheral / cord 
and placental / cord blood samples were compared. The proportion of samples matched 
with identical and partially concordant alleles is shown in Figure 2, which summarizes the 
number of alleles found in peripheral, placental and cord blood. Some samples revealed 
the same alleles in the three compartments. In other cases, one or both samples had 
alleles not detected in the other ones.  
Fig. 2: comparison of P. falciparum MSP-2 alleles detected in paired peripheral, placental and cord blood 
from Congolese women at delivery. (A) 3D7 family. (B) FC27 family.  
3.4. Multiplicity of P. falciparum infections 
The MOI was 1.4±0.01 (ranged 1-4 clones) in peripheral, 1.2±0.01 (range 1-3 clones) in 
placental and 1.4±0.01 (ranged 1-3 clones) in cord samples.  Of 114 infected samples 
from peripheral blood, 110 (96.5%) contained single and 40 (35.1%) multiples infections.  
Of the 70 infected samples from placental blood, 46 (65.7%) harboured single and 24 
(34.3%) multiples infections. In cord, 32 (91.4%) of 35 infected samples contained 
multiples infections and 3 (8.6%) samples have single infection. The MOI was neither 
affected by maternal age, nor gravidity or SP doses administered (Table 4).  
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Table 4: Multiplicity of P. falciparum infections according to age of mother, gravidity and SP doses 
administered. Prevalence of infection determined by PCR, including positive peripheral, placental and/or 
cord samples. Multiplicity of infections = mean number of P. falciparum genotypes per infected woman. The 
columns labelled P indicate the P-value of a mean comparison test, based on either the Wilcoxon test or 
Kruskal-Wallis test depending on the number of groups. The null hypotheses are explicated in the column 
header.   
4. Discussion
The current study is the first of its kind to evaluate the frequency of sub-microscopic P. 
falciparum infection among malaria asymptomatic Congolese women at delivery. The main 
findings of this study are the high prevalence of sub-microscopic infection at delivery, high 
diversity of parasites circulating in the population, and differential patterns of MSP-2 allelic 
 
Multiplicity of P. falciparum infections (range) in the different compartments 
Periphery P Placenta P Cord P 
Overall 1.4 (1-4) 1.2 (1-3) 1.4 (1-3) 
Age (year). Wilcoxon test with H0: m (< 18) = m (≥ 18). 
< 18 1.4 (1-2) 
0.79 
1.3 (1-2) 
0.78 
2.0 (1-2) 
0.88 
≥ 18 1.4 (1-4) 1.2 (1-3) 1.4 (1-3) 
Gravidity. Wilcoxon test with H0: m(Paucigravidae) = m(Multigravidae). 
Paucigravidae 1.4 (1-3) 
0.26 
1.1 (1-3) 
0.94 
1.3 (1-3) 
0.26 
Multigravidae 1.3 (1-4) 1.3 (1-3) 1.4 (1-3) 
IPTp-SP. Kruskal-Wallis test with H0: m(no dose) = m(1 dose) = m(2 doses) = m(3 doses) 
No 1.2 (1-2) 
0.39 
1.1 (1-2) 
0.39 
1.7 (1-3) 
0.39 
1 dose 1.4 (1-3) 1.2 (1-3) 1.7 (1-3) 
2 doses 1.6 (1-4) 1.1 (1-2) 1.6 (1-3) 
3 doses 1.1 (1-3) 1.3 (1-3) 1.1 (1-3) 
families in matched peripheral, placental and umbilical cord parasite isolates from even the 
same individual. 
The prevalence of sub-microscopic P. falciparum infection in the peripheral and placental 
blood was higher than microscopic infection in all compartments. In the cord compartment, 
the P. falciparum infection was found only by PCR. This indicates that the threshold of 
detection of P. falciparum by microscopy in pregnant women strongly under-estimates the 
actual infection rates (Francine et al., 2016; Mockenhaupt et al., 2000). Thus, reliance on 
microscopy may lead to miss diagnosis and failure to avert adverse effect of malaria during 
pregnancy (Mockenhaupt et al., 2000; Ntoumi et al., 2013; Ntoumi et al., 2016). 
The prevalence of sub-microscopic infection was generally high at delivery. This suggests 
that pregnant women remained at increased risk of new infections during the late period of 
their pregnancies after receiving IPTp-SP, which is mostly administered during the second 
trimester. This increased danger may explain why despite the risk of infection being 
significantly reduced among delivered women who received 2 or 3 doses of IPTp-SP, there 
were still about 20% who harboured sub-microscopic infection. The proportion of sub-
microscopic infection in our study is quite small compared to those reported from Gabon 
(Tshibola et al., 2014). This difference might be due to the transmission intensity of the 
parasite at the different study sites and possibly differential host factors such as a degree 
of immunity that might restrict parasites growth to microscopically undetectable levels. 
Alternatively, these low-density infections may represent recently acquired infections, 
which could reach detectable levels by microscopy if infections were not treated. 
All microscopic placental blood infections were microscopically detectable in the peripheral 
blood. However, 42 women with sub-microscopic infection of the placental blood showed 
no evidence of peripheral blood infection. During pregnancy, parasites expressing a ligand 
for chondroitin sulphate A tend to adhere to placenta and sequester in this unique 
compartment (Fried and Duffy, 1996) and are rarely detected in the peripheral blood. This 
might have accounted for the observation made in these 42 participants. The prevalence 
of placental P. falciparum infection was lower than peripheral, which is consistent with 
some of the previous reports (Omalu et al., 2012; Hviid et al., 2011) but not with others 
 
(Mayengue et al., 2004; Ouédraogo et al., 2012). The high prevalence of infection in 
peripheral than placenta blood may explain the new P. falciparum infections in third 
trimester of pregnancy.  
Asymptomatic P. falciparum infection is highly prevalent in malaria endemic regions, which 
raises a serious concern about the efforts at eliminating the parasite (Riley et al., 2001). 
Particularly, sub-patent malaria is still transmissible and will complicate the elimination of 
malaria in high-transmission regions (Sturrock et al., 2013). Most studies suggested that 
exposed individuals are likely to carry chronic asymptomatic P. falciparum infections 
(Sturrock et al., 2013; Ouédraogo et al., 2016), a situation in which the majority of this 
population can act as a reservoir for malaria transmission.  
Our results showed 15 women with sub-microscopic infection in the cord samples with no 
evidence of infection in peripheral and/or placental samples. The unique presence of 
certain parasites in the cord can be explained by parasite clearance in the placenta and / 
or maternal-foetal transfusions before or during birth (Riley et al. 2001). 
The MSP-2 marker is very polymorphic. We detected 24 distinct 3D7 alleles and 20 distinct 
FC27 alleles. Similar results were observed in Gabon (Kassberger et al., 2002, Mayengue 
et al., 2004) in Senegal (Schleiermacher et al., 2001). The 3D7/MSP2 allele was 
predominant such as reported in the previous report in the same site (Francine et al., 
2016). Similar results are observed in Senegal (Jafari-Guemouri et al., 2005), Sudan 
(Fadlelseed et al., 2017). In Gabon, the predominant allele was FC27/MSP2 (Kassberger 
et al., 2002, Mayengue et al., 2004). Allelic frequencies are very different from one family 
to another and the distribution of these alleles reveals the genetic variability present in the 
parasite population and might reflect the geographical variation of parasite genotype and 
the level of transmission.  
Multi-clonal infection was detected respectively in 40 (35.1%), 24 (34.3%) and 32 (91.4%) 
of the peripheral, placental and cord samples. These results are the characteristic of the 
stable malaria transmission area (Mayengue et al., 2004). 
The MOI could be used in the evaluation of malaria interventions as it is an indicator of 
malaria infection in humans and may, to some extent, reflect transmission and immunity 
malaria (Smith et al., 1999). In this cohort the MOI is lower than that reported (about 1.6 
MOI) in the previous study in the same site (Francine et al., 2016) and in other malaria 
endemic area (Beck et al., 2001; Walker-Abbey et al., 2005).  Furthermore, The low MOI 
could be explained by the use of impregnated mosquito nets and the degree of immunity. 
As a result, the low parasite density of this study, which results in low MOI, can be 
observed, but this did not affect the diversity of the parasites in circulation (Ibara-
Okabande et al., 2012).  
The high prevalence of asymptomatic malaria in young pregnant women and those in their 
first and second pregnancies than those in their third or more pregnancies have reported 
(Smith et al., 1999). With successive pregnancies, women acquire a gravidity-dependent 
anti-malarial immunity, resulting in a decrease in both prevalence and severity of infection 
(Smith et al., 1999). Studies have demonstrated a correlation between the MOI and 
parasite density as well as age of the study participants (Mayengue et al., 2004; Omer et 
al., 2011). In our study, MOI was associated with neither maternal age nor gravidity, which 
is in line with other study (Kassberger et al., 2002, Walker-Abbey et al., 2005). Age and the 
acquisition of pregnancy-related immunity do not appear to result in elimination of 
parasites or reduction of the number of different infecting strains. The SP doses have not 
reduced the MOI. This might result from the carriage of SP-resistant parasites in such 
women as suggested earlier (Moussiliou et al., 2013, Koukouikila-Koussounda et al., 2015; 
Ojurongbe et al., 2018). 
The cross-sectional nature of the study did not allow participants to be followed until 
delivery. The lack of current entomological data during the collection of samples and the 
lack of data on the use of mosquito nets by pregnant women do not allow us to deepen the 
analyses on the low multiplicity of infections. 
5. Conclusions
In summary, this study showed that there is a high prevalence of sub-microscopic infection 
and a moderate genetic diversity of Plasmodium falciparum. Age, gravidity and doses of 
preventive treatment based on sulfadoxine-pyrimethamine do not interfere with the 
multiplicity of infections. These results contribute to the understanding of the dynamic of 
parasites in blood sample types during pregnancy and parasite population circulating in 
Congo. 
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